Skip to main content

MetWorks 1.1.0, RefSeq 26, Gentelligent, BasePro 1.0, Tripos Topomer CoMFA, ProteOn Manager 2.0

Thermo Fisher Scientific has launched MetWorks 1.1.0, a new version of its metabolite identification software. Metworks 1.1.0 is compatible with all Thermo Scientific mass spectrometers capable of performing MS/MS and MSn fragmentation. Key improvements include automatic generation of a data-dependent parent mass table; component filtering to exclude duplicates originating from adducts and isotopic contributions; and the ability to apply up to six multiple mass defect filters.

The National Center for Biotechnology Information has released RefSeq 26.
RefSeq 26 includes 6,698,250 records, 4,234,906 proteins, and sequences from 4,737 different organisms.

Gentelligent has launched BasePro 1.0, an Excel-based software package for handling DNA, RNA, and protein data. Base Pro is a downloadable Excel add-in with more than 40 functions for manipulating biological sequences. It is compatible with Excel 2002, 2003, and 2007, and with Windows 2000, Windows XP, and Windows Vista. A 30-day trial is available here.

Tripos has released Tripos Topomer CoMFA, a 3D quantitative structure-activity relationship tool that creates models for predicting the level of biological activity or other properties of chemical compounds. Tripos said that the new product can create Topomer CoMFA models “in minutes, not days and usually produces results comparable to the established CoMFA methods.”

Bio-Rad has released ProteOn Manager 2.0, a new version of the data-management software for its ProteOn XPR36 protein interaction array system.

ProteOn Manager 2.0 includes performance enhancements that reduce processing and analysis time to 34 seconds from two minutes, the company said. The new software also offers “one button” data processing and the ability to more easily import sample lists from spreadsheet software programs and export raw, processed, and analyzed data.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.